Cargando…

Specific Activation of the Cysteine Protease CPP32 during the Negative Selection of T Cells in the Thymus

Cysteine proteases of the CED-3 and ICE family have been recently proposed as the ultimate executioners in several mammalian cell death pathways. Among them, the cysteine protease CPP32 has been shown to participate in programmed cell death (PCD), or apoptosis, affecting lymphoid cells in vitro. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Alam, Antoine, Braun, Michel Y., Hartgers, Franca, Lesage, Sylvie, Cohen, Luchino, Hugo, Patrice, Denis, François, Sékaly, Rafick-Pierre
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199117/
https://www.ncbi.nlm.nih.gov/pubmed/9348308
_version_ 1782148138213048320
author Alam, Antoine
Braun, Michel Y.
Hartgers, Franca
Lesage, Sylvie
Cohen, Luchino
Hugo, Patrice
Denis, François
Sékaly, Rafick-Pierre
author_facet Alam, Antoine
Braun, Michel Y.
Hartgers, Franca
Lesage, Sylvie
Cohen, Luchino
Hugo, Patrice
Denis, François
Sékaly, Rafick-Pierre
author_sort Alam, Antoine
collection PubMed
description Cysteine proteases of the CED-3 and ICE family have been recently proposed as the ultimate executioners in several mammalian cell death pathways. Among them, the cysteine protease CPP32 has been shown to participate in programmed cell death (PCD), or apoptosis, affecting lymphoid cells in vitro. In the thymus, negative selection is a mechanism through which developing thymocytes expressing a TcR with high affinity for self peptide–MHC complexes are eliminated by PCD. In order to investigate the role of CPP32 in thymic apoptosis, isolated thymocytes were submitted to cell surface CD3 crosslinking by immobilized anti-CD3 mAb or to dexamethasone treatment. Although apoptosis occurred in the absence or after crosslinking with anti-CD3 mAb, specific activation of CPP32, as assessed by the extent of proteolytic cleavage of the p32 zymogen, was only detected in thymocytes cultured in the presence of the immobilized antibody or dexamethasone. This activation was a very early event during apoptosis as it occurred before the exposure of phosphatidyl serine to the upper side of the cell membrane. This was observed both in anti–CD3- and dexamethasone-induced apoptosis. Moreover, using mice transgenic for pigeon cytochrome C (PCC)-specific TcR, we were able to show that, after injection of PCC, the activation of CPP32 and cleavage of its substrate occurred in thymocytes obtained from mice expressing a permissive MHC haplotype for PCC presentation (H-2k). Moreover, PCC induced apoptosis was blocked by the caspase inhibitor zVAD. While spontaneous apoptosis was not accompanied by detectable levels of CPP32 processing, it was characterized by the proteolysis of poly(ADP-ribose) polymerase (PARP) and was blocked by the cysteine protease inhibitor, zVAD-CH2F. Taken together, these results support the concept that CPP32 is among the earliest effectors of the pathway leading to negative selection of autoreactive thymocytes. Our results also suggest the involvement of a distinct CPP32-like cysteine protease in spontaneous apoptosis of thymocytes.
format Text
id pubmed-2199117
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21991172008-04-16 Specific Activation of the Cysteine Protease CPP32 during the Negative Selection of T Cells in the Thymus Alam, Antoine Braun, Michel Y. Hartgers, Franca Lesage, Sylvie Cohen, Luchino Hugo, Patrice Denis, François Sékaly, Rafick-Pierre J Exp Med Article Cysteine proteases of the CED-3 and ICE family have been recently proposed as the ultimate executioners in several mammalian cell death pathways. Among them, the cysteine protease CPP32 has been shown to participate in programmed cell death (PCD), or apoptosis, affecting lymphoid cells in vitro. In the thymus, negative selection is a mechanism through which developing thymocytes expressing a TcR with high affinity for self peptide–MHC complexes are eliminated by PCD. In order to investigate the role of CPP32 in thymic apoptosis, isolated thymocytes were submitted to cell surface CD3 crosslinking by immobilized anti-CD3 mAb or to dexamethasone treatment. Although apoptosis occurred in the absence or after crosslinking with anti-CD3 mAb, specific activation of CPP32, as assessed by the extent of proteolytic cleavage of the p32 zymogen, was only detected in thymocytes cultured in the presence of the immobilized antibody or dexamethasone. This activation was a very early event during apoptosis as it occurred before the exposure of phosphatidyl serine to the upper side of the cell membrane. This was observed both in anti–CD3- and dexamethasone-induced apoptosis. Moreover, using mice transgenic for pigeon cytochrome C (PCC)-specific TcR, we were able to show that, after injection of PCC, the activation of CPP32 and cleavage of its substrate occurred in thymocytes obtained from mice expressing a permissive MHC haplotype for PCC presentation (H-2k). Moreover, PCC induced apoptosis was blocked by the caspase inhibitor zVAD. While spontaneous apoptosis was not accompanied by detectable levels of CPP32 processing, it was characterized by the proteolysis of poly(ADP-ribose) polymerase (PARP) and was blocked by the cysteine protease inhibitor, zVAD-CH2F. Taken together, these results support the concept that CPP32 is among the earliest effectors of the pathway leading to negative selection of autoreactive thymocytes. Our results also suggest the involvement of a distinct CPP32-like cysteine protease in spontaneous apoptosis of thymocytes. The Rockefeller University Press 1997-11-03 /pmc/articles/PMC2199117/ /pubmed/9348308 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Alam, Antoine
Braun, Michel Y.
Hartgers, Franca
Lesage, Sylvie
Cohen, Luchino
Hugo, Patrice
Denis, François
Sékaly, Rafick-Pierre
Specific Activation of the Cysteine Protease CPP32 during the Negative Selection of T Cells in the Thymus
title Specific Activation of the Cysteine Protease CPP32 during the Negative Selection of T Cells in the Thymus
title_full Specific Activation of the Cysteine Protease CPP32 during the Negative Selection of T Cells in the Thymus
title_fullStr Specific Activation of the Cysteine Protease CPP32 during the Negative Selection of T Cells in the Thymus
title_full_unstemmed Specific Activation of the Cysteine Protease CPP32 during the Negative Selection of T Cells in the Thymus
title_short Specific Activation of the Cysteine Protease CPP32 during the Negative Selection of T Cells in the Thymus
title_sort specific activation of the cysteine protease cpp32 during the negative selection of t cells in the thymus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199117/
https://www.ncbi.nlm.nih.gov/pubmed/9348308
work_keys_str_mv AT alamantoine specificactivationofthecysteineproteasecpp32duringthenegativeselectionoftcellsinthethymus
AT braunmichely specificactivationofthecysteineproteasecpp32duringthenegativeselectionoftcellsinthethymus
AT hartgersfranca specificactivationofthecysteineproteasecpp32duringthenegativeselectionoftcellsinthethymus
AT lesagesylvie specificactivationofthecysteineproteasecpp32duringthenegativeselectionoftcellsinthethymus
AT cohenluchino specificactivationofthecysteineproteasecpp32duringthenegativeselectionoftcellsinthethymus
AT hugopatrice specificactivationofthecysteineproteasecpp32duringthenegativeselectionoftcellsinthethymus
AT denisfrancois specificactivationofthecysteineproteasecpp32duringthenegativeselectionoftcellsinthethymus
AT sekalyrafickpierre specificactivationofthecysteineproteasecpp32duringthenegativeselectionoftcellsinthethymus